{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:23:37Z","timestamp":1747207417645,"version":"3.40.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2021,9,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cancer is a very dangerous disease whose treatment can be improved by removing the\nfactors that cause side effects if the drugs prescribed for cancer are chiral in nature.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>A computational evaluation for the most biologically active enantiomeric form of chiral drugs attacking\nthe DNA of the cell, was made for the first time, and compared with the experimental work done by\nothers previously.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>All the enantiomeric structures of the drugs taken in the present study were obtained using Marvin\nsketch, and the structure of DNA to be docked with enantiomers, was obtained from the protein data bank. After\nthat, all the enantiomers of the chiral drugs were docked with DNA one by one for the evaluation of the\nmost biologically active enantiomeric form.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The docking study showed that the different enantiomers interacted with DNA differently because of\nhaving different arrangements of atoms\/groups. The binding affinity of one of the two enantiomeric forms was\nhigher than that of another.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> R-methotrexate for breast cancer; R-mitotane for adrenocortical cancer; R-duvelisib for blood cancer,\nand S-irinotecan for colon cancer would be a suitable drug with less toxicity as well as other side effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520621999201230233811","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T07:53:18Z","timestamp":1609487598000},"page":"2075-2081","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Advanced Computational Evaluation for the Most Biologically Active Enantiomers of Chiral Anti-Cancer Agents"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1836-6951","authenticated-orcid":true,"given":"Mohd","family":"Suhail","sequence":"first","affiliation":[{"name":"Department of Chemistry, Jamia Millia Islamia, (A Central University) Jamia Nagar, New Delhi-110025, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-8374","authenticated-orcid":true,"given":"Imran","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Jamia Millia Islamia, (A Central University) Jamia Nagar, New Delhi-110025, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/189671","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189671\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/189671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T11:11:29Z","timestamp":1631272289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189671\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":0,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,9,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621999201230233811","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}